HealthCareCentral

Sunday, March 6, 2011

Pfizer's Biggest Shot at Lipitor 2.0 (ABT, AMGN, INCY, JNJ, MRK, PFE, RIGL)

Pfizer's Biggest Shot at Lipitor 2.0 (ABT, AMGN, INCY, JNJ, MRK, PFE, RIGL)
Posted by Whatasmartguy at 6:29 PM
Email ThisBlogThis!Share to XShare to FacebookShare to Pinterest

No comments:

Post a Comment

Newer Post Older Post Home
Subscribe to: Post Comments (Atom)

Total Pageviews

Followers

Blog Archive

  • ►  2019 (1)
    • ►  October (1)
  • ►  2016 (1)
    • ►  April (1)
  • ►  2014 (1)
    • ►  December (1)
  • ▼  2011 (17)
    • ▼  March (15)
      • Making sense of the Alzheimer's drug pipeline - Fi...
      • Novartis Has Largest Japan Exposure Among Big Phar...
      • Did China Just Change Its Growth Model? - Gordon G...
      • Pfizer's Biggest Shot at Lipitor 2.0 (ABT, AMGN, I...
      • Six trends that will change the fundamentals of ph...
      • BBC - Fergus's Medical Files: Lab-grown brain cell...
      • HCA Returning Three Times Cost Shows Timing Trumps...
      • Is the New iPad 2 Worth the Cost?
      • Kidney Cancer Awareness
      • Cancer Awareness Ribbons, Cancer Wristbands and Ca...
      • M&A and the Pharma Industry.
      • EU Approval for Xiapex - Yahoo! Finance
      • King Pharmaceuticals, Inc. Announces Final Results...
      • Bayer Reports Unexpected Fourth-Quarter Loss on Sc...
      • Is Eli Lilly a Stock for the Long Term? (LLY, MRK,...
    • ►  February (2)

About Me

My photo
Whatasmartguy
View my complete profile
Picture Window theme. Theme images by ImagesbyTrista. Powered by Blogger.